Brief: N4 Pharma Says US Patent Attorney Granting Further Patent Application For Nuvec In U.S.
July 25 (Reuters) - N4 Pharma PLC N4P.L :
* N4 PHARMA PLC - PATENT GRANT AND BOARD CHANGE
* N4 PHARMA - NOTIFIED BY US PATENT ATTORNEY OF GRANTING OF
ITS
FURTHER PATENT APPLICATION FOR NUVEC® IN U.S.
* N4 PHARMA PLC - JOHN CHIPLIN, CURRENTLY NON-EXECUTIVE
CHAIRMAN,
IS RETIRING FROM BOARD
Source text for Eikon: ID:nRSY0209Ha
Further company coverage: N4P.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Thalia Therapeutics
See all newsThalia Therapeutics - Interim Results
Brief: Thalia Therapeutics Says New Patent Granted For Miristen In China
Thalia Therapeutics - New Patent Granted for miRisten in China
Thalia Therapeutics - RNA gene-silencing cardiovascular program advances
Thalia Therapeutics - Business Update and Notice of Results